Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
IlDong Pharmaceutical Co Ltd clinical trials
Part of Ildong Holdings Co., Ltd., which holds 30.65% as of 2026-03-31. Source
The registry lists 50 studies whose lead sponsor is IlDong Pharmaceutical Co Ltd. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 24, 2024.
Keep track of what changes. Save the IlDong Pharmaceutical Co Ltd studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to IlDong Pharmaceutical Co Ltd.
- IlDong Pharmaceutical Co Ltd50 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 50 of 50.
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult SubjectsRecruitingNCT06635226Phase 1
- Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult SubjectsCompletedNCT06063291Phase 1
- Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic EffectsTerminatedNCT05604287Phase 1
- Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside AnaloguesCompletedNCT02792088Phase 3
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of ID120040002 in Healthy VolunteersStatus unknownNCT05663879Phase 1
- IDG-16177 for the Evaluation of Its Safety and PharmacokineticsStatus unknownNCT04982705Phase 1
- To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult VolunteersStatus unknownNCT05259020Phase 1
- Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in KoreanCompletedNCT04218162Phase 3
- Pharmacokinetics of Besifovir in Adults With Normal and Impaired Renal FunctionStatus unknownNCT04249908Phase 1
- Phase 3 and Extensional Study of BesifovirStatus unknownNCT01937806Phase 3
- To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male AdultsStatus unknownNCT04185090Phase 1
- Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil MaleateStatus unknownNCT04202536Phase 4
- Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and EfficacyCompletedNCT03761082
- Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's DiseaseCompletedNCT03363269Phase 2
- qQ-lab Daily-IBS for Irritable Bowel SyndromeCompletedNCT03964103Not applicable
- Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy VolunteersStatus unknownNCT03937648Phase 1
- Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic DermatitisStatus unknownNCT03907228Not applicable
- A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and HydrochlorothiazideCompletedNCT03889145Phase 1
- A Food Effect Study of Besifovir in Healthy SubjectsCompletedNCT03885778Phase 4
- Dose-escalation, Repeated and Single Oral Dosing StudyTerminatedNCT02419820Phase 1
- Safety Study of APD-791 With Aspirin and/or ClopidogrelTerminatedNCT02034292Phase 1
- Belviq Tablet® Post Marketing Surveillance ProtocolStatus unknownNCT03741010
- Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and EfficacyStatus unknownNCT03742544
- A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/EzetimibeStatus unknownNCT03648788
- A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus.Status unknownNCT03655288
- A Post-marketing Surveillance to Assess Safety and Efficacy of BesivoStatus unknownNCT03642340
- A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab.Status unknownNCT03648801
- Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed DyslipidemiaCompletedNCT02262143Phase 3
- Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty LiverStatus unknownNCT03604016Phase 4
- Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With HyperlipidemiaCompletedNCT03566316Phase 3
- A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)CompletedNCT02749994Phase 3
- Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With HypertensionCompletedNCT02145104Phase 3
- Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male VolunteersCompletedNCT02739672Phase 1
- Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male VolunteersCompletedNCT03032315Phase 1
- Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension PatientsCompletedNCT02738632Phase 3
- The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile DysfunctionStatus unknownNCT02862483Phase 3
- Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.Status unknownNCT02831543Phase 3
- Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate HyperplasiaStatus unknownNCT02827578Phase 3
- A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and ValsartanCompletedNCT02343250Phase 1
- Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult VolunteersCompletedNCT02300688Phase 1
- The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia PatientsStatus unknownNCT02251847Phase 3
- Study for Comparing The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male SubjectsCompletedNCT02103686Phase 1
- Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg and Immediate Release FormulationCompletedNCT02103647Phase 1
- A Drug Interaction Study of Mosapride and RebamipideCompletedNCT02106130Phase 1
- A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male SubjectsCompletedNCT02088918Phase 1
- Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With HyperlipidemiaStatus unknownNCT02087540Phase 3
- A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and ValsartanStatus unknownNCT02088008Phase 1
- A Phase I Study of IDP-73152 Mesylate in Health Male VolunteerCompletedNCT01904318Phase 1
- A Drug Interaction Study of Cilnidipine and ValsartanCompletedNCT01838967Phase 1
- Pharmacokinetic Study of Belviq in Adult Korean VolunteersCompletedNCT01880502Phase 1